TET2 and hematologic disorder: A survey of TET2 mutations in the COSMIC database showed more deleterious mutations in hematological malignancies than in solid tumors (29.8% versus 7.3% for frameshift mutations and 28.1% versus 10.3% for nonsense mutations).